Image

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Study of Investigational Medication in Adults with Refractory/Recurrent Metastatic Cancer

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates refractory/recurrent metastatic cancer. It includes adults with certain types of advanced cancer.

The study evaluates the safety and anti-tumor activity of an investigational medication. It looks at how well the medication works and how safe it is for people to take.

  • Who can participate: Adults aged 18 and older with metastatic or locally advanced solid tumors can participate. Participants must have measurable disease and adequate organ function.
  • Study details: Participants will receive an investigational medication. Some may also receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Head and Neck Squamous Cell Carcinoma HNSCC
    Non-Small Cell Lung Cancer NSCLC
    Esophageal Cancer
    Gastric Cancer
    Colorectal Cancer
    Pancreatic Ductal Adenocarcinoma (PDAC)
    Cervical Cancer
    Endometrial Cancer
    Urothelial Cancer

NCT07227168

Sutro Biopharma, Inc.

5 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.